Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Insilico Medicine
AddedFeb 13, 2024
UpdatedJun 18, 2026
Insilico Medicine

Insilico Medicine

Insilico Medicine: A global AI biotech firm dedicated to extending human productive longevity.

HQ
New York City, NY, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Insilico Medicine is a global AI biotechnology firm dedicated to extending human productive longevity. Headquartered in Hong Kong, with R&D and management resources across the USA, Belgium, Russia, UK, Taiwan, and China, the company leverages AI to develop innovative solutions in drug discovery and development. Key products include the PHARMA.AI suite, PandaOmics, Generative Biologics, Chemistry42, and inClinico.

Insilico Medicine has achieved significant milestones in AI-driven drug discovery, partnering with leading pharmaceutical companies and research institutions. The company has been recognized for its pioneering work in integrating AI with biotechnology, contributing to advancements in healthcare and longevity. Notable figures in the organization include its founder and CEO, Alex Zhavoronkov, and a distinguished scientific advisory board.

Insilico Medicine - Products & Services

  • Pharma.ai logo

    Pharma.ai

    Pharma.ai is Insilico Medicine's generative AI platform for drug discovery, target identification, and molecule design.

    Competing Products

    Lila Sciences logo
    Lila Sciences logo
    Isomorphic Labs logo
    Genesis Therapeutics logo

Insilico Medicine - Similar Companies

Lila Sciences logo

Lila Sciences

lila.ai

Genesis Therapeutics logo

Genesis Therapeutics

Isomorphic Labs logo

Isomorphic Labs

isomorphiclabs.com

Insitro logo

Insitro

insitro.com

Insilicom logo

Insilicom

insilicom.com

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Owkin logo

Owkin

owkin.com

Biosim logo

Biosim

Recursion Pharmaceuticals logo

Recursion Pharmaceuticals

recursion.com

Insilica logo

Insilica

insilica.co

XtalPi logo

XtalPi

xtalpi.com

Model Medicines logo

Model Medicines

modelmedicines.com

Zephyr AI logo

Zephyr AI

zephyrai.bio

DeepCure logo

DeepCure

deepcure.ai

Generate Biomedicines logo

Generate Biomedicines

Insilico Medicine - Quick Facts

Who are Insilico Medicine's competitors?

Companies similar to Insilico Medicine include Lila Sciences, Genesis Therapeutics, Isomorphic Labs and Insitro.

When was Insilico Medicine founded?

Insilico Medicine was founded in 2014.

Where is Insilico Medicine's headquarters located?

Insilico Medicine's headquarters is located in New York City, NY, US.

When was Insilico Medicine's last funding round?

Insilico Medicine's most recent funding round was for $35M (USD) in August 2022.

How much has Insilico Medicine raised to-date?

As of Aug 10, 2022, Insilico Medicine has raised a total of $401.3M (USD).

How many employees does Insilico Medicine have?

Insilico Medicine has 278 employees as of Feb 4, 2024.

Insilico Medicine - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Tags
  • AI Operations
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 23 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research